Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland

350 to 400 manufacturing jobs and about 1,000 construction jobs expected to be created

State-of-the-art facility will produce multiple therapies for the company’s growing biologics portfolio

Significant investment builds on 50 years of company’s manufacturing history in Ireland

350 to 400 manufacturing jobs and about 1,000 construction jobs expected to be created

(NEW YORK – November 14, 2014) - Bristol-Myers Squibb Company (NYSE: BMY) today announced plans to construct a new state-of-the-art, large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland, that will produce multiple therapies for the company’s growing biologics portfolio. Once completed, the new facility will significantly increase Bristol-Myers Squibb’s biologics manufacturing capacity and play a central role in its global manufacturing network.

 

Read Press Release